KARLOX (Meloxicam USP)
7.5mg Tablets https://luckasluck.click/karlox-meloxicam-usp/
:كارلوکس
ملی گرام
۵ املی گرام
امیلو کسی کم ہو ایس پی )
گولیاں
Each tablet contairis: Meloxicam USP
7.5mg
(USP Specs)
Karlox 15mg tablets: Each tablet contains
Meloxicam USP
15mg
(USP Specs)
Drug Category: Oxicam
Pharmacokinetic properties Absorption:
Meloxicam is well absorbed from the gastrointestinal tract, which reflected by a high absolute bioavailability of 89% following oral administration (Tablet). Following single dose administration of meloxicam, mean maximum plasma concentrations achieved within 2 hours for the suspension and within 5-6 hours with solid oral dosage forms (tablets)
5. With multiple dosing, steady state conditions were reached within 3 to days. Once daily dosing leads to drug plasma concentrations with a relatively small peak-trough fluctuation in the range of 0.4-1.0 µg/ml for 7.5 mg doses and 0.8-2.0 µg/ml for 15 mg dossa, respectively (Cmin and Cmax at steady state, respectively). Distribution: Meloxicam is very strongly bound to plasma proteins, essentially albumin (99%). Meloxicam penetrates into synovial fluid to give concentrations approximately half of those in plasma
Meloxicant undergoes extensive hepatic biotransformation.The major metabolite, 5
carboxy meloxicam (60% of dose), is formed by oxidation of an Intermediate metabolite 5- hydroxymethylmeloxicam, which is also excreted to a lesser extent (9% of dose). In vitro studies suggest that CYP 209 plays an important role in this metabolic pathway, with a minor contribution from the CYP 3A4 isoenzyme. The patient’s peroxidase activity is probably responsible for the other two matabolites, which account for 16% and 4% of the administered dose respectively.
Elimination:
Meloxicam is excreted predorninantly in the form of metabolites and occurs to equal extents in urine and faeces. Less than 5% of the daily dose is excreted unchanged in faeces, while only traces of the parant compound are excreted in urine.
The mean elimination half-life is about 20 hours, Total plasma clearance amounts on average 8 mL/min. Linearity/non-linearity
Meloxicam demonstrates linear pharmacokinetics in the therapeutic dose range of 7.5 mg 15 mg. following per oral or intramuscular adminiştration.
Short-Term Symptomatic Treatment of Exacerbations of Osteoarthritis Long Term Symptomatic Trealment of Rheumatoid Arthritis or Ankylosing Spondylitis.
Dosage: Adult: ORAL: Osteoarthritis:
7.5 mg tablet once daily, of necessary to max 15 mg once daily
Rheumatoid arthritis, ankylosing spondylitis: 15 mg tablet ornice daily
Children:
Rallef of pain and inflarnymation in juvenile idiopathic arthritis and other musculoskeletal disorders in children intolerant to other NSAIDs: ORAL
12-18 yr and body-weight under 50 kg.
unusual bruising or bleeding, chest pain, palpitations, fast heartbeat, swelling in extremities, blood in urine/stool/mouth/vomitus, acute fatigue, skin rash, itching, blister, lever, changes in hearing, ringing in eans,
yellowing of skin or eyes, difficulty in speaking.
Pregnancy: Risk cannot be ruled out.
Lactation: Contraindicated or not recommended.
Active peptic ulcer, GI bleeding, aspirin/anti-inflammatory induced allergy, severa hepatic or renal failure, severe CHF, active inflammatory
bowel disease, cerebrovascular bleeding, bleeding disorder, Treatment of pain after CABG
Precaution: Congestive heart failure, liver cirrhosis, nephrotic syndrome, ranal
failure, hypovolemia, Gi upset, hypertension, ischaemic heart disease, peripheral arterial disease, cerebrovascular disease, other cardiovascular risk factors Elderly.
Anticoagulants, lithium, IUDs, methotrexate, cholestyramine, diuretics, cyclosporin, antihypertensives, thrombolytics, other NSAIDS. tacrolinius, antiplatelets, SSRIs, corticosteroids.
Adverse effects:
Also for the perforation, ulceration, bleeding or upset, monitor patient. Muco- cutaneous reactions including pruritus, rash, urticarial, angioedema,
photosensitivity, erythema multiforme, Stevens-Johnson syndrome. CNS or cardiovascular effects, blood dyscrasias, transient disturbances in liver tests. Headache, Glupset, fluid and electrolyte disturbances.
As directed by the physician:
Store at room temperature (15°C-25°C). Protect from sunlight. Keep
away from the reach of children
Karlox 7.5mg tablets: Pick of 10’s.
Karlox 15mg tablets: Pack of 10’s.
خوراک ڈاکٹر کی ہدایت کے مطابق استعمال کریں۔
ہدایات دور کو کمرے کے درجہ حرارت (1500 سے 25 ) پر رکھیں۔ روشنی، دھوپ اورنگی سے بچائیں۔ بچوں کی بھی ہے اور رگیں ۔
صرف رجسٹر ڈ ڈاکٹر کے نسخہ پر فر وخت کریں۔
Manufactured by:
KARSONS PHARMACEUTICALS
Plot No. 01, Street No. SS-3, National Industrial Zone Rawat Rawalpindi-Pakistan